Posted on 05/01/2020 8:49:46 AM PDT by SeekAndFind
FRIDAY, May 1, 2020 (HealthDay News) -- A 3-week-old Texas infant in critical condition with COVID-19 was successfully treated and recovered, doctors report.
This is one of the first cases of its kind, according to the team of doctors at the University of Texas Health Science Center at Houston (UTHealth).
They noted that the initial belief that children aren't at risk of serious illness from COVID-19 has been disproved as more information is gathered on the disease caused by the new coronavirus.
"We are still so early in the research and data available on COVID-19, and as providers, we need to be aware that children can get critically ill from this virus," said study first author Dr. Alvaro Coronado Munoz, an assistant professor of pediatric critical care medicine at UTHealth.
"It's important for parents to understand that they should not delay seeking care for their children if there's any presence of fever or trouble breathing," Coronado said in a university news release.
In the team's case report, the child arrived at a hospital with nasal congestion, rapid breathing and heart rate, reduced eating, a temperature of 97 degrees, and low oxygen saturation. The child was transferred to a pediatric intensive care unit (PICU), and arrived there with low blood pressure, hypothermia and continued rapid heart rate and breathing.
Lung X-rays revealed signs of pneumonia. Instead of waiting for nasal swab test results that could take weeks, doctors took immediate action.
Coronado said that after seeing the lung X-rays, "we were suspicious immediately that it could be the coronavirus. We took early precautions to protect our team and avoid the spread to health care providers."
After five days, the infant was discharged from the PICU. On day nine, the infant had recovered and was sent home without supplemental oxygen, according to the case study published recently in the New England Journal of Medicine.
"While this case is limited to one single patient, it illustrates that severe COVID-19 cases in children can occur, but also be successfully managed," Coronado said.
Thank God for “anecdotes”!
That baby would have died without HCQ!
RE: Thank God for anecdotes!
Search the word: “Anecdotal” in this FR site and you will get heaps of such anecdotes for Hydroxychloroquine. I deliberately added that word in the parenthesis of titles so that searches can be made easy.
WEEKS??? How can that be? Why don't hospital labs have tests available that can return results in an hour? We've read that many universities got FDA approval to use their own in-house tests. There was a flurry of reporting on that four to six weeks ago when the FDA relaxed its regulatory requirements, but then it just disappeared from the news.
I think so. It is an amazing story.
Absolutely. Among those who have died, I would bet that at least a quarter to a half would have survived had the HCQ cocktail been dispensed early and prophylactically.
“Puff, the magic dragon lived by the sea
Because he took hydroxychloroquine and survived anecdotely
The story is from May 1st and said the patient had been released after 9 days but there is no indication when the child was taken to the hospital. Maybe this was back when the testing was just starting and only CDC and state labs could run tests.
This is not an anecdote. It is a case study. This is where the physicians involved describe the patient and their treatment regimen, with the intent of passing useful information to other physicians.
Glad the baby recovered.
Where do we disagree? If I grew SOB, I would beg my doc for the HCQ cocktail.
Anecdote was obviously used wryly, tongue-in-cheek.
Thank heaven for this HCQ treatment.
Praying this infant doesn’t have any longterm lung damage/issues, or any other horrid, long term China Flu side effects.
What the heck is wrong with that kid? Don’t these people know that hydroxychloroquine is not allowed to be successful?
I believe the bulk of the “anecdotal” data shows it is closer to 90% do not even need hospitalization (Zev Zelenko’s results), especially when coupled with zinc.
With our betters (erm, I mean governors) writing executive orders like Walz and nutters in MI and NY, etc witholding fairly well proven and scientifically based treatments until people are hospitalized, it is no wonder we have less stellar results.
The below is from lupus.org (you can check any state’s actions on this there).
https://www.lupus.org/advocate/state-action-on-hydroxychloroquine-and-chloroquine-access#
Minnesota
On March 27, Minnesota Governor Tim Walz issued executive order 20-23 which stated that prescriptions for hydroxychloroquine or chloroquine must contain a diagnosis appropriate for the use of these medications and be dispensed for no more than 30 days and authorized the states Board of Pharmacy to enforce the order.
The Board of Pharmacy issued guidance related to the executive order, and clarified that the phrase diagnosis appropriate for use means any FDA-approved indication for the drug (which would include lupus for both), and at this time, does not include COVID-19. The Board goes on to note that the 30-day limit applies to all diagnoses and empowers pharmacists to contact the prescriber to question higher-than-normal doses for the diagnosis, presumably as a way to get around the 30-day limit.
Just on the use of the word “anecdote.” An anecdote is the type of story “I heard that my neighbor’s sister’s husband’s boss was cured of Covid by taking a mixture of silver nitrate, garlic powder, and aloe!” Whereas a case study is a group of physicians describing their experience with a specific case.
As for hydroxychloroquine, I think the jury is still out. Careful studies have not been completed.
I would take it in a second if I needed treatment. Zelenko convinced me.
I would take it in a second if I needed treatment. Zelenko convinced me.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.